In Axia Growth's analysis of closed small-business sales, behavioral health practices are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, 21 traditional behavioral health M&A deals closed in Q2 2026, with mental health leading at 14.
Mental health is the most active corner of behavioral health M&A, but 2026 volume is down. Mertz Taggart counted 21 closed traditional deals in Q2 2026, its lightest quarter since 2022, with mental health leading at 14. Buyers are paying for in-network, growing outpatient practices and pricing Medicaid exposure more cautiously. Substance-use treatment is the weakest segment, with just 2 addiction-treatment deals closed in the quarter.
Why published multiples differ
Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.
Multiples by deal size
Sector: Healthcare. Median and middle half (p25-p75) of sale price to earnings.
Closed small-business sales in the Healthcare sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size band
n
Median multiple
p25-p75
Basis
Under $500K SDE
182
3.4x
2.7x-4.2x
SDE
$500K-$1M SDE
42
3.4x
2.5x-4.4x
SDE
$1M-$2M SDE
22
3.3x
2.7x-7.5x
SDE
$2M-$3M EBITDA
13
5.1x
3.1x-10.9x
EBITDA
$5M-$10M EBITDA
14
8.8x
3.4x-10.7x
EBITDA
$10M+ EBITDA
17
12.9x
9.4x-18.5x
EBITDA
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.
No published cell for the Healthcare size band: $3M-$5M EBITDA. Each has fewer than 10 closed sales, so Axia Growth does not estimate a multiple for it.
How much is a behavioral health business worth?
Behavioral health businesses sell for a multiple of earnings. In Axia Growth's Healthcare sector data, businesses with under $500K of SDE sold for a median 3.4x SDE, with the middle half between 2.7x and 4.2x, across 182 closed sales. With $500K-$1M of SDE, the median was 3.4x SDE (42 sales).
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.
Substance-use treatment is the weak spot. Addiction treatment produced only 2 of the quarter's closed deals, against 14 in mental health. Medicaid is a heavy payer for this segment, which ties its deal flow closely to Medicaid policy.
Regulatory exposure gets its own workstream. DEA and HHS extended telemedicine prescribing flexibilities through December 31, 2026, but permanent rules are not final. A practice that relies on remote prescribing of controlled substances must show how its model works if the flexibilities end.
What raises the multiple
An outpatient behavioral health practice that commands a premium typically shows:
In-network commercial contracts with several payers, and Medicaid as a minority of revenue.
A clinician bench, including psychiatric prescribers, that does not depend on the founder's caseload.
Measurable access and outcomes data, such as time to first appointment and standardized symptom scores.
A telehealth and prescribing model that complies with current DEA rules and can adapt if they change.
Clean credentialing, documentation, and billing audit results.
Room to add higher-acuity or interventional services, such as IOP or TMS, without new licensure barriers.
Reliable behavioral-health-specific multiples for small practices are not publicly available. Smaller private deals generally price below larger private-equity deals, and small-practice sale data varies widely, so payer mix, clinician depth, and growth matter more than any sector average.
State review laws affect timing. A Mertz Taggart tally finds at least 14 states now require advance notice to the attorney general or a related agency before a private equity, hedge fund, or MSO-affiliated healthcare transaction closes. Behavioral health practices that use an MSO structure should expect this review in those states.
Expect outpatient mental health to keep leading volume over the next 12 to 24 months, with substance-use deals recovering slowly. Medicaid-heavy substance-use providers carry the most policy risk, since buyers are already underwriting Medicaid more cautiously than in years past.
Three dates will shape pricing: the end of DEA telemedicine flexibilities on December 31, 2026, the proposed parity rule due by the same date, and pending Medicaid policy changes. Practices with commercial in-network revenue and compliant prescribing models are best placed to hold value through those changes.
In Axia Growth's analysis of closed small-business sales, behavioral health practices are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, 21 traditional behavioral health M&A deals closed in Q2 2026, with mental health leading at 14.
What multiple do behavioral health practices sell for?
Axia Growth groups behavioral health practices in the Healthcare sector, the closest published proxy: businesses with under $500K of SDE sold for a median 3.4x SDE across 182 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).
SDE or EBITDA: which applies to my behavioral health practice?
Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Healthcare sector, Axia Growth publishes both SDE and EBITDA bands.
Can a behavioral health practice keep prescribing controlled substances by telehealth after a sale?
For now. DEA and HHS extended telemedicine flexibilities through December 31, 2026, so registered practitioners can still prescribe without a prior in-person visit. Buyers test what happens to a practice's prescribing model if those flexibilities lapse. Source: Gordon Rees Scully Mansukhani.
How does Medicaid exposure affect a behavioral health valuation?
It is a major diligence item. Medicaid is the single largest payer of behavioral health services in the country, and Mertz Taggart reports buyers are underwriting Medicaid more cautiously than in years past. Sources: KFF; Mertz Taggart.
How do I get a value range for my business?
Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.
In Axia Growth's analysis of closed small-business sales, behavioral health practices are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, 21 traditional behavioral health M&A deals closed in Q2 2026, with mental health leading at 14. What is a behavioral health practice worth? 21 deals closed in Q2 2026, 14 in mental health. Example: Talkspace agreed to an $835M sale. What buyers pay up for.
When using information from this guide, cite Axia Growth and link to this page.
Axia Growth. Behavioral Health & Counseling M&A. Updated 2026-10-30. https://axiagrowth.com/resources/industries/healthcare/behavioral-health-counseling
For buyers
Have a mandate in Behavioral Health & Counseling? Share your buy box.
Axia Growth LLC provides deal origination services and is not a registered broker-dealer, investment adviser, bank, or depository institution. Where Axia's compensation is contingent on closing, it relies on the M&A broker exemption (15 U.S.C. § 78o(b)(13)) and analogous state exemptions, where available. Axia is typically engaged and paid by the acquirer, does not represent sellers, and does not provide, arrange, or receive compensation for transaction financing. See full disclaimer: /legal/disclaimer